2001
DOI: 10.2337/diabetes.50.9.1959
|View full text |Cite
|
Sign up to set email alerts
|

The Neuropeptide Pituitary Adenylate Cyclase–Activating Polypeptide and Islet Function

Abstract: The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) is ubiquitously distributed in both the central and peripheral nervous systems and exerts a variety of effects. PACAP is a neuropeptide in pancreatic islets, where it has been suggested as a parasympathetic and sensory neurotransmitter. PACAP stimulates insulin secretion in a glucose-dependent manner, by an effect executed mainly through augmenting the formation of cAMP and stimulating the uptake of calcium. Accumulating evidence in an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
63
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(64 citation statements)
references
References 97 publications
(164 reference statements)
1
63
0
Order By: Relevance
“…Furthermore, VPAC 2 -/-mice exhibit reduced insulin secretion but maintained glucose tolerance after intravenous administration of glucose, suggesting peripheral effects on insulin sensitivity (Asnicar et al, 2002). Furthermore, PACAP and VIP both stimulate glucagon secretion as has been demonstrated both in humans, in animals and in vitro (Filipsson et al 2001). …”
Section: Pac 1 Vpac 1 and Vpac 2 Receptorsmentioning
confidence: 78%
See 1 more Smart Citation
“…Furthermore, VPAC 2 -/-mice exhibit reduced insulin secretion but maintained glucose tolerance after intravenous administration of glucose, suggesting peripheral effects on insulin sensitivity (Asnicar et al, 2002). Furthermore, PACAP and VIP both stimulate glucagon secretion as has been demonstrated both in humans, in animals and in vitro (Filipsson et al 2001). …”
Section: Pac 1 Vpac 1 and Vpac 2 Receptorsmentioning
confidence: 78%
“…These receptors are linked to the G s -protein with subsequent elevation of cAMP and stimulation of insulin secretion (Filipsson et al, 2001). Disruption of the PAC 1 receptor in mice results in impaired insulin secretion after PACAP administration (Jamen et al 2000).…”
Section: Pac 1 Vpac 1 and Vpac 2 Receptorsmentioning
confidence: 99%
“…It is a widespread neuropeptide that is secreted by intraislet nerves and stimulates insulin secretion (44). It is a substrate for DPP-4 (45), and therefore its rapid inactivation might be inhibited during treatment with DPP-4 inhibition.…”
Section: Prevention Of Inactivation Of Other Biologically Active Peptmentioning
confidence: 99%
“…Neuropeptides that are stored in islet nerve terminals and affect islet function would be of particular relevance in this regard, and the islet autonomic nervous system is indeed sometimes overlooked as an important regulator of islet function [18]. One neuropeptide of potential importance is pituitary adenylate cyclase-activating peptide (PACAP), which is localised to islet nerves and has several actions relevant to glucose homeostasis [19]. For example, PACAP is a powerful stimulator of insulin secretion and may, like GLP-1, be of importance for islet mass.…”
mentioning
confidence: 99%